Lilly's $3.8 Billion Vaccine Bets: A Quiet Shift Now
Lilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
Financial planning can be overwhelming. Find out where to start and set yourself on the path to financial success.
20,577 articlesLilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
A deep dive into mib: jean eric salata, chair of EQT, exploring how cross-cultural experience and AI-driven infrastru...
Can Nvidia keep leading in AI and data centers through 2030? This in-depth look lays out three scenarios, key drivers...
CVS Health is leveraging its vast network to tap into the GLP-1 weight-loss wave. This explainers-backed piece breaks...
Remote work holds steady around 22% of US workers in early 2026, defying headlines of a mass office return. New data ...
Sirius XM stunned investors with a near-50% rise in the first half of 2026. This analysis breaks down the catalysts, ...
As AI data centers demand more power, nuclear options like NuScale Power and Constellation Energy rise in relevance. ...
Looking for biotech growth with real upside? This piece breaks down two innovative biotech stocks that could deliver ...
The market loves dramatic headlines about AI threatening legacy tech, but the real story is nuanced. This piece expla...
DTI's 2025 earnings narrative sheds light on demand for drilling tools and oilfield equipment. This guide breaks down...
A rare moment of optimism surrounds Uber as Dara Khosrowshahi signals a sharper focus on execution and profitability....
A new venue now enables 24/7 crypto trading, including weekends. Early weekend data shows growing interest and liquid...